Lymphoma is one of the most common hematologic malignancies and accounts for approximately 4% of cancer diagnoses in the US. Lymphoma has many subtypes with various factors to consider in response assessment, including medical imaging review. Lugano classification became the main response criteria in 2014, and since there have been several challenges and pitfalls addressed using the criteria. In this webinar, MERIT discusses the fundamentals of Lugano classification, data collection, and recent academia and industry recommendations on challenges of assessment.
3 key questions that are answered:
1. What are the fundamentals of Lugano classification?
2. What data collection elements are needed when reading Lugano classification?
3. What are the challenges and updated recommendations from industry/academia in Lymphoma reading assessments?